Diverse combination therapies are being investigated to overcome the limitations of immune checkpoint inhibitors. However, determining the optimal combination therapy remains a challenge. Herein, we d

DataCite Commons2024-03-01 更新110

Table_4_The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.xlsx

癌症免疫治疗

耐药性突变

Cancer somatic mutations have been identified as a source of antigens that can be targeted by cancer immunotherapy. In this work, expanding on previous studies, we analyze the HLA-presentation propert

NIAID Data Ecosystem60

Supplementary Material for: Preoperative systemic chemotherapy including immune checkpoint inhibitors for patients with tumor-associated dermatomyositis.

癌症免疫治疗

自身免疫疾病基因组关联

Introduction: Immune checkpoint inhibitors (ICIs), used in cancer immunotherapy, enhance the immune system's ability to attack cancer cells. However, this activation can lead to severe immune-associat

DataCite Commons2025-01-16 更新40

Additional file 8 of Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma

癌症免疫治疗

基因分析

Additional file 8: Table S4. The CIBERSORT results of LUSC patients from TCGA database.

DataCite Commons2024-08-14 更新70

TMEscore and grouping information of samples used for subsequent analysis.

肿瘤微环境评分

癌症免疫治疗

(XLSX)

NIAID Data Ecosystem50